D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2017
NCT03177538
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology